CDK4 Cancer Research Results
CDK4, Cyclin-dependent kinase 4: Click to Expand ⟱
| Source: |
| Type: |
Cyclin-dependent kinase 4 (CDK4) is a key regulator of the cell cycle, particularly in the transition from the G1 phase to the S phase. Its expression and activity are often altered in various cancers, contributing to tumorigenesis.
CDK4 is frequently overexpressed in various cancers, and its expression levels can serve as a prognostic marker.
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
TumCP↓, ROS↑, Apoptosis↑, Bcl-2↓, p‑PI3K↓, p‑Akt↓, BAX↑, Casp3↑, Casp9↑, Cyt‑c↑, CycD3↓, CycB/CCNB1↓, CDK1↓, CDK2↓, CDK4↓, P21↑, p27↑, P53↑, tumCV↓, PI3K↓, Akt↓,
CSCs↓, TumCCA↑, cMyc↓, cycD1/CCND1↓, CDK4↓, MMP↓, Casp↑, CD133↓, CD44↓, ALDH1A1↓, Nanog↓, OCT4↓, SOX2↓, Wnt↓, β-catenin/ZEB1↓, EGFR↓,
tumCV↓, TumCCA↑, pRB↓, cycD1/CCND1↓, CDK4↓, CDK6↓, PI3K↓, p‑Akt↓, Apoptosis↑, Bcl-2↓, BAX↑,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 2, Apoptosis↑, 2, BAX↑, 2, Bcl-2↓, 2, Casp↑, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, p27↑, 1,
Transcription & Epigenetics ⓘ
pRB↓, 1, tumCV↓, 2,
DNA Damage & Repair ⓘ
P53↑, 1,
Cell Cycle & Senescence ⓘ
CDK1↓, 1, CDK2↓, 1, CDK4↓, 3, CycB/CCNB1↓, 1, cycD1/CCND1↓, 2, CycD3↓, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
ALDH1A1↓, 1, CD133↓, 1, CD44↓, 1, CSCs↓, 1, Nanog↓, 1, OCT4↓, 1, PI3K↓, 2, p‑PI3K↓, 1, SOX2↓, 1, Wnt↓, 1,
Migration ⓘ
TumCP↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1,
Hormonal & Nuclear Receptors ⓘ
CDK6↓, 1,
Clinical Biomarkers ⓘ
EGFR↓, 1,
Total Targets: 39
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CDK4, Cyclin-dependent kinase 4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:894 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page